These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
785 related items for PubMed ID: 18931333
1. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG. Am J Respir Crit Care Med; 2009 Jan 15; 179(2):151-7. PubMed ID: 18931333 [Abstract] [Full Text] [Related]
14. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis. Lewis C, Sanderson R, Vasilottos N, Zheutlin A, Visovatti S. Heart Fail Clin; 2023 Jan 15; 19(1):45-54. PubMed ID: 36435572 [Abstract] [Full Text] [Related]
15. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask! Sanges S, Sobanski V, Lamblin N, Hachulla E, Savale L, Montani D, Launay D. Rev Med Interne; 2024 Jan 15; 45(1):26-40. PubMed ID: 37925256 [Abstract] [Full Text] [Related]
16. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. Coghlan JG, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, Kuwana M, McLaughlin VV, Peacock AJ, Simonneau G, Vachiéry JL, Blair C, Gillies H, Miller KL, Harris JHN, Langley J, Rubin LJ, AMBITION investigators. Ann Rheum Dis; 2017 Jul 15; 76(7):1219-1227. PubMed ID: 28039187 [Abstract] [Full Text] [Related]